USING PHARMACOECONOMIC MODELLING TO DETERMINE VALUE-BASED PRICING FOR NEW MEDICINES

Purpose: to carry out pharmacoeconomic modeling for an early economic evaluation of the generic pegylated liposomal doxorubicin (PLD) drug.Materials and methods: a Markov model and Decision tree model were developed to simulate and to compare the costs and effects of new generic PLD versus doxorubic...

Full description

Saved in:
Bibliographic Details
Main Authors: I. S. KRYSANOV, V. Yu. ERMAKOVA, A. V. ZABOROVSKY, K. G. GUREVICH
Format: Article
Language:Russian
Published: Ministry of Healthcare of the Russian Federation. “Kuban State Medical University” 2017-05-01
Series:Кубанский научный медицинский вестник
Subjects:
Online Access:https://ksma.elpub.ru/jour/article/view/670
Tags: Add Tag
No Tags, Be the first to tag this record!